Ocugen (OCGN) Income from Continuing Operations (2014 - 2026)

Ocugen (OCGN) reported Income from Continuing Operations of 19059000.0 for Q1 2026, down 23.3% on a YoY basis from 24847265.08 in Q1 2025, and down 4.69% quarter-over-quarter from 18205000.0 in Q4 2025.

Ocugen (OCGN) Income from Continuing Operations (2014 - 2026) Analysis & Trends

Ocugen has reported Income from Continuing Operations for 13 years, with the latest figure at 19059000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations fell 23.3% year-over-year to 19059000.0; the trailing twelve-month figure through Mar 2026 stood at 70849000.0 (down 22.71% YoY), and the FY2025 full-year result was 67182000.0, down 23.97% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 19059000.0, down from 18205000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 11525000.0 in Q4 2023, with the low at 23540000.0 in Q2 2023.
  • Historically, Income from Continuing Operations has averaged 17088176.47 across 5 years, with a median of 18035000.0 in 2023.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 168.9% — and 2023, when it surged 47.47%.
  • Ocugen's Income from Continuing Operations stood at 21939000.0 in 2022, then jumped by 47.47% to 11525000.0 in 2023, then slipped by 21.76% to 14033000.0 in 2024, then decreased by 29.73% to 18205000.0 in 2025, then dropped by 4.69% to 19059000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 19059000.0 (Q1 2026), 18205000.0 (Q4 2025), and 18732000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Ocugen 411.07 Mn 411.07 Mn - -19.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.06 Mn
Dec 31, 2025 -18.21 Mn
Sep 30, 2025 -18.73 Mn
Jun 30, 2025 -14.85 Mn
Mar 31, 2025 -15.46 Mn
Dec 31, 2024 -14.03 Mn
Sep 30, 2024 -12.97 Mn
Jun 30, 2024 -15.28 Mn
Mar 31, 2024 -11.91 Mn
Dec 31, 2023 -11.53 Mn
Sep 30, 2023 -12.43 Mn
Jun 30, 2023 -23.54 Mn
Mar 31, 2023 -18.04 Mn
Dec 31, 2022 -21.94 Mn
Sep 30, 2022 -21.92 Mn
Jun 30, 2022 -21.58 Mn
Mar 31, 2022 -19.03 Mn
Dec 31, 2021 -14.58 Mn
Sep 30, 2021 -10.76 Mn
Jun 30, 2021 -25.62 Mn